pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ARROWHEAD PHARMACEUTICALS, INC. ($ARWR) · news · pharmadog
← back to ARROWHEAD PHARMACEUTICALS, INC.
News mentioning $ARWR
9
stories
6d
Arrowhead’s Ionis problem, Kyverna’s next-gen end and more biotech earnings
biospace
Oct 15, 26
Arrowhead’s blood-brain barrier tech is ‘arguably better’ than others, analysts say after data drop
biospace
Oct 13, 26
Roche expands obesity R&D footprint with Rona deal worth $1B+
biospace
Oct 13, 26
Roche inks $1.2B deal with China's Rona to enter emerging ALK7 obesity race
fiercebiotech
Aug 31, 26
Arrowhead's new Redemplo findings in severe hypertriglyceridemia have analysts split
biospace
Aug 11, 26
Epicrispr lands $90M to advance epigenetic editing drug for rare muscle disease
biopharma dive
Aug 7, 26
‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit
biopharma dive
Jul 29, 26
Biotechs bring big launches and pharma rivalries into Q2 earnings period
biospace
Jul 22, 26
Arrowhead puts pressure on Ionis with positive data for triglyceride lowering drug
biospace